A link between FTO, ghrelin, and impaired brain food-cue responsivity

Journal of Clinical Investigation

Volumn 123, Issue 8, 2013, Pages 3539-3551

  Karra, Efthimia ^a   O'Daly, Owen G ^b   Choudhury, Agharul I ^c   Yousseif, Ahmed ^a   Millership, Steven ^c   Neary, Marianne T ^a   Scott, William R ^a   Chandarana, Keval ^a   Manning, Sean ^a   Hess, Martin E ^d,e,f   Iwakura, Hiroshi ^g   Akamizu, Takashi ^g   Millet, Queensta ^a   Gelegen, Cigdem ^a   Drew, Megan E ^a   Rahman, Sofia ^a   Emmanuel, Julian J ^a   Williams, Steven C R ^b   Rüther, Ulrich U ^h   Brüning, Jens C ^d,e,f   Withers, Dominic J ^c   Zelaya, Fernando O ^b   Batterham, Rachel L ^a,i   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF COLOGNE   (Germany)

^e UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^f MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

^g KYOTO UNIVERSITY HOSPITAL   (Japan)

^h HEINRICH HEINE UNIVERSITY   (Germany)

ⁱ UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

6 N METHYLADENOSINE; ACYL GHRELIN; FAT MASS AND OBESITY ASSOCIATED PROTEIN; GHRELIN; MESSENGER RNA; PEPTIDE; PROTEIN; UNCLASSIFIED DRUG;

ADULT; APPETITE; ARTICLE; ASSOCIATION; BODY COMPOSITION; BODY FAT; BOLD SIGNAL; BRAIN REGION; CALORIC INTAKE; CAUDATE NUCLEUS; CONTROLLED STUDY; FAT MASS; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE OVEREXPRESSION; GENETIC RISK; GENOTYPE; HOMOZYGOSITY; HUMAN; HUNGER; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; METHYLATION; NERVE POTENTIAL; OBESITY; PRIORITY JOURNAL; REWARD;

ACYLTRANSFERASES; ADOLESCENT; ADULT; ANIMALS; APPETITE; BRAIN; EATING; FOOD; FUNCTIONAL NEUROIMAGING; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDIES; GHRELIN; HEK293 CELLS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METHYLATION; MICE; MICE, KNOCKOUT; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; REWARD; RIBOSOMAL PROTEINS; RNA, MESSENGER; YOUNG ADULT;

EID: 84881257670     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI44403     Document Type: Article

References (74)

1. Gerken T, et al. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science. 2007;318(5855):1469- 1472.
2. Frayling TM, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316(5826):889-894.
3. Dina C, et al. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet. 2007;39(6):724-726.
4. Hardy R, et al. Life course variations in the associations between FTO and MC4R gene variants and body size. Hum Mol Genet. 2010;19(3):545-552.
5. Li H, et al. Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. Diabetologia. 2012;55(4):981-995.
6. Lauria F, et al. Prospective analysis of the association of a common variant of FTO (rs9939609) with adiposity in children: results of the IDEFICS study. PLoS One. 2012;7(11):e48876.
7. Cecil JE, Tavendale R, Watt P, Hetherington MM, Palmer CN. An obesity-associated FTO gene variant and increased energy intake in children. N Engl J Med. 2008;359(24):2558-2566.
8. Speakman JR, Rance KA, Johnstone AM. Polymorphisms of the FTO gene are associated with variation in energy intake, but not energy expenditure. Obesity (Silver Spring). 2008;16(8):1961-1965.
9. Wardle J, Llewellyn C, Sanderson S, Plomin R. The FTO gene and measured food intake in children. Int J Obes (Lond). 2009;33(1):42-45.
10. Timpson NJ, et al. The fat mass- and obesity-associated locus and dietary intake in children. Am J Clin Nutr. 2008;88(4):971-978.
11. Tanofsky-Kraff M, et al. The FTO gene rs9939609 obesity-risk allele and loss of control over eating. Am J Clin Nutr. 2009;90(6):1483-1488.
12. Wardle J, Carnell S, Haworth CM, Farooqi IS, O'Rahilly S, Plomin R. Obesity associated genetic variation in FTO is associated with diminished satiety. J Clin Endocrinol Metab. 2008;93(9):3640-3643.
13. den Hoed M, Westerterp-Plantenga MS, Bouwman FG, Mariman EC, Westerterp KR. Postprandial responses in hunger and satiety are associated with the rs9939609 single nucleotide polymorphism in FTO. Am J Clin Nutr. 2009;90(5):1426-1432.
14. Velders FP, et al. FTO at rs9939609, food responsiveness, emotional control and symptoms of ADHD in preschool children. PLoS One. 2012;7(11):e49131.
15. McTaggart JS, Lee S, Iberl M, Church C, Cox RD, Ashcroft FM. FTO is expressed in neurones throughout the brain and its expression is unaltered by fasting. PLoS One. 2011;6(11):e27968.
16. Stratigopoulos G, et al. Regulation of Fto/Ftm gene expression in mice and humans. Am J Physiol Regul Integr Comp Physiol. 2008;294(4):R1185-R1196.
17. Fredriksson R, et al. The obesity gene, FTO, is of ancient origin, up-regulated during food deprivation and expressed in neurons of feeding-related nuclei of the brain. Endocrinology. 2008;149(5):2062-2071.
18. Olszewski PK, et al. Hypothalamic FTO is associated with the regulation of energy intake not feeding reward. BMC Neurosci. 2009;10:129.
19. Wang P, et al. Involvement of leptin receptor long isoform (LepRb)-STAT3 signaling pathway in brain fat mass- and obesity-associated (FTO) downregulation during energy restriction. Mol Med. 2011;17(5-6):523-532.
20. Gutierrez-Aguilar R, Kim DH, Woods SC, Seeley RJ. Expression of new loci associated with obesity in diet-induced obese rats: from genetics to physiology. Obesity (Silver Spring). 2012;20(2):306-312.
21. Boender AJ, van Rozen AJ, Adan RA. Nutritional state affects the expression of the obesity-associated genes Etv5, Faim2, Fto, and Negr1. Obesity (Silver Spring). 2012;20(12):2420-2425.
22. Tung YC, et al. Hypothalamic-specific manipulation of Fto, the ortholog of the human obesity gene FTO, affects food intake in rats. PLoS One. 2010;5(1):e8771.
23. Cheung MK, Gulati P, O'Rahilly S, Yeo GS. FTO expression is regulated by availability of essential amino acids. Int J Obes (Lond). 2013;37(5):744-747.
24. Gulati P, et al. Role for the obesity-related FTO gene in the cellular sensing of amino acids. Proc Natl Acad Sci U S A. 2013;110(7):2557-2562.
25. Fischer J, et al. Inactivation of the Fto gene protects from obesity. Nature. 2009;458(7240):894-898.
26. Gao X, Shin YH, Li M, Wang F, Tong Q, Zhang P. The fat mass and obesity associated gene FTO functions in the brain to regulate postnatal growth in mice. PLoS One. 2010;5(11):e14005.
27. McMurray F, et al. Adult onset global loss of the fto gene alters body composition and metabolism in the mouse. PLoS Genet. 2013;9(1):e1003166.
28. Church C, et al. A mouse model for the metabolic effects of the human fat mass and obesity associated FTO gene. PLoS Genet. 2009;5(8):e1000599.
29. Church C, et al. Overexpression of Fto leads to increased food intake and results in obesity. Nat Genet. 2010;42(12):1086-1092.
30. Jia G, et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol. 2011;7(12):885-887.
31. Dominissini D, et al. Topology of the human and mouse m6A RNA methylomes revealed by m6Aseq. Nature. 2012;485(7397):201-206.
32. Meyer KD, Saletore Y, Zumbo P, Elemento O, Mason CE, Jaffrey SR. Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons. Cell. 2012;149(7):1635-1646.
33. Cummings DE, Overduin J. Gastrointestinal regulation of food intake. J Clin Invest. 2007;117(1):13-23.
34. Wren AM, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001;86(12):5992.
35. Batterham RL, et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature. 2002; 418(6898):650-654.
36. Batterham RL, et al. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med. 2003; 349(10):941-948.
37. Malik S, McGlone F, Bedrossian D, Dagher A. Ghrelin modulates brain activity in areas that control appetitive behavior. Cell Metab. 2008;7(5):400-409.
38. Perello M, et al. Ghrelin increases the rewarding value of high-fat diet in an orexin-dependent manner. Biol Psychiatry. 2010;67(9):880-886.
39. Batterham RL, et al. PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature. 2007;450(7166):106-109.
40. Iwakura H, et al. Establishment of a novel ghrelin-producing cell line. Endocrinology. 2010;151(6):2940-2945.
41. Chandarana K, et al. Subject standardization, acclimatization, and sample processing affect gut hormone levels and appetite in humans. Gastroenterology. 2009;136(7):2115-2126.
42. Balleine BW, O'Doherty JP. Human and rodent homologies in action control: corticostriatal determinants of goal-directed and habitual action. Neuropsychopharmacology. 2010;35(1):48-69.
43. Kroemer NB, et al. (Still) longing for food: Insulin reactivity modulates response to food pictures [published online ahead of print March 28, 2012]. Hum Brain Mapp. doi:10.1002/hbm.22071.
44. Litt A, Plassmann H, Shiv B, Rangel A. Dissociating valuation and saliency signals during decisionmaking. Cereb Cortex. 2011;21(1):95-102.
45. Nummenmaa L, et al. Dorsal striatum and its limbic connectivity mediate abnormal anticipatory reward processing in obesity. PLoS One. 2012;7(2):e31089.
46. Yang J, Brown MS, Liang G, Grishin NV, Goldstein JL. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell. 2008;132(3):387-396.
47. Lappalainen T, et al. Gene expression of FTO in human subcutaneous adipose tissue, peripheral blood mononuclear cells and adipocyte cell line. J Nutrigenet Nutrigenomics. 2010;3(1):37-45.
48. Mager U, et al. Expression of ghrelin gene in peripheral blood mononuclear cells and plasma ghrelin concentrations in patients with metabolic syndrome. Eur J Endocrinol. 2008;158(4):499-510.
49. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000;407(6806):908-913.
50. Abizaid A, et al. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J Clin Invest. 2006;116(12):3229-3239.
51. Perello M, Zigman JM. The role of ghrelin in rewardbased eating. Biol Psychiatry. 2012;72(5):347-353.
52. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402(6762):656-660.
53. Davis JF, et al. GOAT induced ghrelin acylation regulates hedonic feeding. Horm Behav. 2012; 62(5):598-604.
54. Wren AM, et al. Ghrelin causes hyperphagia and obesity in rats. Diabetes. 2001;50(11):2540-2547.
55. Sun Y, Butte NF, Garcia JM, Smith RG. Characterization of adult ghrelin and ghrelin receptor knockout mice under positive and negative energy balance. Endocrinology. 2008;149(2):843-850.
56. Albarran-Zeckler RG, Sun Y, Smith RG. Physiological roles revealed by ghrelin and ghrelin receptor deficient mice. Peptides. 2011;32(11):2229-2235.
57. Zigman JM, et al. Mice lacking ghrelin receptors resist the development of diet-induced obesity. J Clin Invest. 2005;115(12):3564-3572.
58. Wortley KE, et al. Absence of ghrelin protects against early-onset obesity. J Clin Invest. 2005; 115(12):3573-3578.
59. Walker AK, Ibia IE, Zigman JM. Disruption of cue-potentiated feeding in mice with blocked ghrelin signaling. Physiol Behav. 2012;108:34-43.
60. Cota D, et al. Hypothalamic mTOR signaling regulates food intake. Science. 2006;312(5775):927-930.
61. Cota D, Matter EK, Woods SC, Seeley RJ. The role of hypothalamic mammalian target of rapamycin complex 1 signaling in diet-induced obesity. J Neurosci. 2008;28(28):7202-7208.
62. Pan T. N6-methyl-adenosine modification in messenger and long non-coding RNA. Trends Biochem Sci. 2013;38(4):204-209.
63. Niu Y, Zhao X, Wu YS, Li MM, Wang XJ, Yang YG. N6-methyl-adenosine (m6A) in RNA: an old modification with a novel epigenetic function. Genomics Proteomics Bioinformatics. 2013;11(1):8-17.
64. Moran I, et al. Human beta cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes. Cell Metab. 2012;16(4):435-448.
65. Shin AC, Zheng H, Berthoud HR. An expanded view of energy homeostasis: neural integration of metabolic, cognitive, and emotional drives to eat. Physiol Behav. 2009;97(5):572-580.
66. Kroemer NB, et al. Fasting levels of ghrelin covary with the brain response to food pictures [published online ahead of print September 13, 2012]. Addict Biol. doi:10.1111/j.1369-1600.2012.00489.x.
67. Fagerberg B, Hulten LM, Hulthe J. Plasma ghrelin, body fat, insulin resistance, and smoking in clinically healthy men: the atherosclerosis and insulin resistance study. Metabolism. 2003;52(11):1460-1463.
68. Batterink L, Yokum S, Stice E. Body mass correlates inversely with inhibitory control in response to food among adolescent girls: an fMRI study. NeuroImage. 2010;52(4):1696-1703.
69. Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr. 2000; 72(3):694-701.
70. Ramel A, et al. Relationship between BMI and body fatness in three European countries. Eur J Clin Nutr. 2013;67(3):254-258.
71. Ode JJ, Pivarnik JM, Reeves MJ, Knous JL. Body mass index as a predictor of percent fat in college athletes and nonathletes. Med Sci Sports Exerc. 2007; 39(3):403-409.
72. Sondergaard E, Gormsen LC, Nellemann B, Vestergaard ET, Christiansen JS, Nielsen S. Visceral fat mass is a strong predictor of circulating ghrelin levels in premenopausal women. Eur J Endocrinol. 2009;160(3):375-379.
73. Stoeckel LE, Weller RE, Cook EW 3rd, Twieg DB, Knowlton RC, Cox JE. Widespread reward-system activation in obese women in response to pictures of high-calorie foods. NeuroImage. 2008;41(2):636-647.
74. Worsley KJ, Friston KJ. Analysis of fMRI time-series revisited-again. NeuroImage. 1995;2(3):173-181.